We are live on ! Find out more
PC

Paulson & Co Portfolio holdings

AUM $3.11B
1-Year Est. Return 94.93%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+94.93%
3 Year Est. Return
+233.32%
5 Year Est. Return
+258.51%
10 Year Est. Return
+934.97%
AUM
$9.23B
AUM Growth
-$611M
Cap. Flow
-$895M
Cap. Flow %
-9.7%
Top 10 Hldgs %
68.38%
Holding
107
New
21
Increased
16
Reduced
40
Closed
13

Top Buys

Rank Stock Value
1
HPE icon
Hewlett Packard
HPE
+$127M
2
BIIB icon
Biogen
BIIB
+$54.8M
3
DELL icon
Dell
DELL
+$53.1M
4
STE icon
Steris
STE
+$22M
5
EBAY icon
eBay
EBAY
+$19M

Sector Composition

Rank Sector Weight
1 Healthcare 55.75%
2 Consumer Discretionary 10.67%
3 Financials 5.93%
4 Materials 5.09%
5 Technology 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCH
76
DELISTED
Felcor Lodging Trust
FCH
$3.21M 0.03%
500,000
-450,000
-47% -$2.93M
SHOP icon
77
Shopify
SHOP
$169B
$3.19M 0.03%
+742,000
New +$2.83M
INSM icon
78
Insmed
INSM
$22.6B
$2.98M 0.03%
205,200
RIGL icon
79
Rigel Pharmaceuticals
RIGL
$712M
$2.95M 0.03%
80,500
-19,470
-19% -$558K
TLND
80
DELISTED
Talend S.A. American Depositary Shares
TLND
$2.64M 0.03%
+100,800
New +$2.68M
CBOE icon
81
Cboe Global Markets
CBOE
$31.1B
$2.49M 0.03%
+38,412
New +$2.62M
ALDR
82
DELISTED
Alder Biopharmaceuticals
ALDR
$2.42M 0.03%
+74,000
New +$2.25M
DVAX
83
DELISTED
Dynavax Technologies
DVAX
$1.82M 0.02%
174,000
WCIC
84
DELISTED
WCI Communities, Inc.
WCIC
$1.66M 0.02%
+70,000
New +$1.29M
BCRX icon
85
BioCryst Pharmaceuticals
BCRX
$2.48B
$1.6M 0.02%
363,100
+100,000
+38% +$399K
ESPR
86
DELISTED
Esperion Therapeutics
ESPR
$1.41M 0.02%
102,000
ALNY icon
87
Alnylam Pharmaceuticals
ALNY
$38.5B
$1.31M 0.01%
19,300
ARDM
88
DELISTED
Aradigm Corp Common Stock
ARDM
$1.01M 0.01%
146,918
+81,015
+123% +$394K
BAC.WS.B
89
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$894K 0.01%
8,944,186
-16,351
-0.2% -$1.53K
OSG
90
DELISTED
Overseas Shipholding Group Inc.
OSG
$477K 0.01%
45,139
CLDX icon
91
Celldex Therapeutics
CLDX
$2.79B
$286K ﹤0.01%
4,720
LILA icon
92
Liberty Latin America Class A
LILA
$1.67B
$138K ﹤0.01%
+7,793
New +$154K
BKNG icon
93
Booking.com
BKNG
$154B
-42,500
Closed -$2.12M
CI icon
94
Cigna
CI
$79.6B
-61,800
Closed -$7.91M
IQV icon
95
IQVIA
IQV
$40B
-164,200
Closed -$10.7M
PRGO icon
96
Perrigo
PRGO
$1.43B
-12,500
Closed -$1.13M
EGRX
97
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-21,000
Closed -$815K
RAD
98
DELISTED
Rite Aid Corporation
RAD
-29,045
Closed -$4.35M
ENDP
99
CALL
DELISTED
Endo International plc
ENDP
-119,900
Closed -$1.87M
KTWO
100
DELISTED
K2M Group Holdings, Inc
KTWO
-47,500
Closed -$737K

Similar funds

Paulson & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Paulson & Co held 107 positions worth $9.23B, down 6.2% from $9.84B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Paulson & Co withdrew a net $895M in Q3 2016, closing 13 positions and reducing 40 holdings. Its most notable exit was STARWOOD HOTELS & RESORTS WORLDWIDE, INC., an estimated $333M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 53% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Paulson & Co opened a new position in Hewlett Packard worth $136M.

  • Paulson & Co's largest Q3 2016 buy was Hewlett Packard: 10,259,855 shares worth $136M.
  • Paulson & Co added most to Biogen in Q3 2016, an estimated $54.8M increase.
  • Paulson & Co's biggest Q3 2016 reduction was Shire pic, cutting an estimated $103M.
  • Paulson & Co fully exited STARWOOD HOTELS & RESORTS WORLDWIDE, INC. in Q3 2016, selling an estimated $333M.
  • Paulson & Co's ten largest holdings make up 68% of its $9.23B portfolio in Q3 2016.
  • Paulson & Co opened 21 new positions and closed 13 in Q3 2016.
  • Paulson & Co's portfolio value fell 6.2% quarter-over-quarter to $9.23B.

Based on Paulson & Co's 13F filing for Q3 2016, filed 14 Nov 2016.